- Home
- / ITH Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ITH Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
£48.3 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.2M | 12.1M | 15.1M | 20.4M | 26.2M | 30.8M | 38.6M | 48.3M |
| Revenue growth, % | 28.4% | 17.5% | ||||||
| Cost of goods sold | 10.0M | 13.6M | 18.7M | 22.1M | 27.5M | 33.5M | ||
| Gross profit | 5.1M | 6.8M | 7.5M | 8.6M | 11.1M | 14.8M | ||
| Gross profit margin, % | 33.8% | 33.4% | 28.8% | 28.1% | 28.8% | 30.6% | ||
| Operating expense total | 8.1M | 11.6M | 4.5M | 5.5M | 7.1M | 7.9M | 8.8M | 10.9M |
| EBITDA | 325.6K | 695.6K | 911.7K | 1.6M | 635.6K | 1.0M | 2.7M | 4.5M |
| EBITDA margin, % | 4.0% | 5.8% | 6.0% | 7.6% | 2.4% | 3.3% | 7.0% | 9.3% |
| EBIT | 69.9K | 411.1K | 624.0K | 1.3M | 429.3K | 728.7K | 2.3M | 3.9M |
| EBIT margin, % | 0.9% | 3.4% | 4.1% | 6.3% | 1.6% | 2.4% | 5.9% | 8.1% |
| Pre tax profit | 45.6K | 372.5K | 740.5K | 1.2M | 365.5K | 616.7K | 2.1M | 3.7M |
| Income tax expense | (11.5K) | (37.5K) | (193.4K) | (275.2K) | (83.3K) | (122.2K) | (469.3K) | (650.3K) |
| Net Income | 34.1K | 335.0K | 547.1K | 947.3K | 282.2K | 494.6K | 1.7M | 3.1M |